New Cancer Drug Zaltrap Discounted by 50%

By Curt Pesman and Mary Miller In an unusual move, sanofi pharmaceutical company has instituted a 50 percent discount, effective immediately, on its latest cancer drug Zaltrap.  The reason for the sharp price drop, company officials said, was “market resistance” to the initial price. Zaltrap was approved in August by the FDA for second-line treatment for metastatic…  Read More

Cost of Cancer Care Expected to Skyrocket in Next Decade

The U.S. sticker price for cancer care by 2020 will likely increase at least 27% over the next decade, to a minimum $158 billion yearly by 2020, according to the National Cancer Institute. Colorectal cancer ranks 2nd behind breast cancer in 2010 total costs of care by cancer type, and will remain one of the top…  Read More

Colorectal Cancer News in Brief: July 31

Get help managing the financial costs of your cancer care from an ASCO booklet or figure out how to deal with the Medicare prescription doughnut hole using an AARP online calculator. In research, Lynch syndrome women have excellent survival after ovarian cancer, older patients have similar effectiveness and side effects from Avastin, and parents with advanced…  Read More